Dublin, July 08, 2019 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Market" report has been added to ResearchAndMarkets.com's offering.
The global microbiome sequencing market is expected to witness significant growth during the forecast period (2018-2023).
The microbiome sequencing market is driven by numerous factors including an increasing emphasis on microbiome sequencing for early detection and diagnosis. Many market players are engaging in collaborative AI (Artificial Intelligence) for microbiome sequencing to promote studies on gut microbiomes.
In 2018, Viome Inc. developed Vie's AI system. The system uses data gathered from four sources: biological testing, expert knowledge, customer feedback, and scientific literature.
Increased government spending for the promotion of microbiome research is expected to promote the growth of the global market in the future. One such initiative is the Human Microbiome Project (HMP), which began in 2007 as an extension of the Human Genome Project. The project, put forth by the NIH, was initiated to enhance research on microbiomes in the U.S. The cost associated with sequencing technologies has decreased over the past few years.
Microbiome sequencing technology has numerous applications. Companies such as Metagenom Bio and Resphera Biosciences provide microbiome products and services in various sectors: agriculture, mining, computational and bioproducts. Since microbiome sequencing is a new technology, a lack of skilled labor is one factor expected to have a negative impact on the growth of the market.
The global microbiome sequencing market has been segmented on the basis of sequencing technology, components, applications, end users and laboratory types. The global microbiome sequencing market has been segmented into technologies: Sanger Sequencing, High-throughput Sequencing, and Third Generation Sequencing. Sanger Sequencing is the dominant technology in the microbiome sequencing market. Sanger Sequencing is preferred by biologists and researchers due to its accuracy. It offers new perspectives for genome analysis and exploration and is based on the chain termination method.
Key Topics Covered
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Sequencing Technology
Chapter 5 Market Breakdown by Component
Chapter 6 Market Breakdown by Application
Chapter 7 Market Breakdown by End User
Chapter 8 Market Breakdown by Laboratory Type
Chapter 9 Market Breakdown by Region
Chapter 10 Patent Review/ New Developments
Chapter 11 Analysis of Market Opportunities
Chapter 12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/2pvihy
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biopharmaceuticals